Aditxt Inc Sustainability Reports
Aditxt, Inc. is a biotech company focused on developing technologies that map, monitor, and reprogram the human immune system. Its primary platforms aim to address health challenges related to organ transplantation, autoimmune diseases, and allergies.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
LEI: 529900NYTSP9EB7RD741
1 reports from 2023 to 2023
Company Profile
Aditxt, Inc. is a biotech company focused on developing technologies that map, monitor, and reprogram the human immune system. Its primary platforms aim to address health challenges related to organ transplantation, autoimmune diseases, and allergies.
Reports
1 total
Limited sustainability disclosure available
This company only publishes Annual Reports without dedicated sustainability sections.
Years
